Lancashire chemicals factory facing potential legal claim announces closure
AGC Chemicals Europe Announces Potential Closure Amid Controversy
Lancashire chemicals factory facing potential legal - A manufacturing facility in Thornton-Cleveleys, Lancashire, has revealed intentions to potentially shut down its operations. This announcement comes mere days after news emerged that over ninety local inhabitants have registered interest in participating in a possible legal action concerning environmental contamination affecting their community. AGC Chemicals Europe is currently engaging in discussions with both workforce members and union delegates regarding the future of its production site.
The consultation process is anticipated to continue for a minimum of forty-five days. While management has clarified that no definitive conclusion has been reached, they acknowledged that all one hundred and ninety permanent workers alongside eighteen temporary agency personnel would face consequences. According to an official company communication, the proposal stems from what they described as "significant financial and operational challenges, generating a loss for the past four years."
Chemical Contamination and Health Concerns
The Thornton-Cleveleys plant sits at the heart of ongoing scrutiny regarding its historical release of Pfoa. This substance, formally known as perfluorooctanoic acid, belongs to the Pfas family—per- and polyfluoroalkyl substances—which have earned the nickname "forever chemicals" due to their persistence in natural ecosystems. International scientific studies have established connections between Pfoa exposure and kidney cancer development.
Since acquiring the facility in 1999, AGC Chemicals Europe utilized Pfoa in the production of PTFE, or polytetrafluoroethylene, a material widely recognized for creating non-stick surfaces. The chemical was subsequently prohibited worldwide in 2020. Historical records indicate that between the 1950s and 2012, the factory released approximately forty-nine tonnes of this carcinogenic compound into the surrounding environment.
Environmental authorities and municipal officials conducted comprehensive testing of soil quality and locally grown produce. Following the discovery of extensive soil pollution, local inhabitants received guidance to thoroughly wash and peel vegetables cultivated at home while refraining from consuming eggs sourced from nearby farms. Additionally, two community garden areas near the factory have been temporarily closed.
Legal Action and Scientific Findings
Recent research commissioned by government bodies uncovered kidney cancer incidence rates exceeding expectations in the vicinity of the manufacturing plant. Although the investigation identified no definitive cancer cluster or direct environmental correlation, prominent specialists characterized these results as a "major source of concern" and recommended additional examinations, including blood analysis.
Previously uncovered internal records showed that AGC Chemicals Europe sponsored primate testing during the late 1990s. Several monkeys participating in these trials passed away, and every individual subject demonstrated elevated liver weight—a recognized indicator of chemical toxicity.
Legal representatives from Leigh Day contacted AGC Chemicals Europe last week, announcing their examination of a potential lawsuit representing Sam Hammond, a local resident whose pet duck eggs contain substantial Pfoa concentrations. Analysis revealed that the Pfoa level in one of her duck's eggs was sufficiently elevated that consuming merely one egg weekly would result in Pfas exposure ten times greater than the European safety threshold.
Leigh Day stated that this legal matter relates to the "loss of enjoyment and usage" of Hammond's property alongside potential personal health damages. More than ninety locals have expressed willingness to join any forthcoming legal proceedings, with fifty individuals undergoing blood examinations throughout the summer months. Similar contamination disputes in the United States have already produced settlements worth billions of dollars.
Company Response and Future Obligations
Addressing the closure announcement, AGC Chemicals Europe emphasized that it takes "responsibilities to protect employees, the local community and the environment very seriously." The organization further noted that should manufacturing halt, it would maintain dedication to fulfilling all regulatory requirements, including retaining adequate personnel for environmental permit adherence and conducting any required monitoring activities.
Regarding recent public statements, the corporation informed the Guardian that "while it would not be appropriate to comment on individual cases or allegations, the multi-agency health cell report concluded that there was no evidence of a statistically significant kidney cancer cluster, no clustering of cases close to the current AGC Chemicals Europe Ltd site, and no indication of a link to environmental levels."
Although AGC Chemicals Europe discontinued Pfoa usage in 2012, the facility continues manufacturing and releasing EEA-NH4, another Pfas variant. The Health and Safety Executive is currently deliberating whether to categorize this particular chemical as a "possible carcinogen," a decision that could influence future operational requirements and potential legal exposure for the company.